1. Yarchoan R, Klecker RW, Weinhold KJ, et al. Administration of 3’-azido-3’-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet 1986; i:575–80.
2. Fischl MA, Richman DD, Grieco MH, et al, and the AZT Collaborative Working Group. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987; 317: 185–91.
3. Fischl MA, Richman DD, Causey DM, et al, and the AZT Collaborative Working Group. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. JAMA 1989; 262: 240510.
4. Richman DD, Andrews J. Results of continued monitoring of participants in the placebo-controlled trial of zidovudine for serious human immunodeficiency virus infection. Am J Med 1988; 85: 208–13.
5. Fischi MA, Richman DD, Hansen N, et al, and the AIDS Clinical Trials Group. The safety and efficacy of zidovudine (AZT) in the treatment of patients with mildly symptomatic HIV infection. A double-blind placebo-controlled trial. The AIDS Clinical Trials Group. Ann Int Med 1990; 112: 727–37.